Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Equine expert calls for lameness redefinition
Professor René Van Weeren.
Advanced technology allowing researchers to study the horse’s gait

An equine expert has suggested that lameness needs to be redefined to reflect new digital assessment techniques.

In a paper published in the Equine Veterinary Journal, René Van Weeren - a professor of equine musculoskeletal biology at Utrecht University - points out that digital systems rely on preset parameters to decide about lameness and that this can present obstacles.

He writes that thresholds are based on a limited reference population, which doesn’t accurately reflect the millions of horses in the world. The individual environmental and mental conditions for each horse are not accounted for. As such, to use the term ‘lame’ because a horse demonstrated a subtle gait alteration could be inappropriate, particularly as it may not affect the horse’s welfare in any way.

Professor Van Weeren said: “Digital equine gait analysis is sure to become an indispensable additional tool for clinical decision-making. At this early stage, we must define the use of terminology in order to avoid confusion and to prevent the formation of wrong perceptions.

“Using the term “lame” for any horse falling beyond thresholds set for quantitative gait analysis or not showing the ideal motion pattern when assessed clinically is inadvisable. We should reserve the use of that term for horses deemed unfit to compete based on a comprehensive assessment of the animal that includes, but does not rely entirely on, the appreciation of the degree of gait asymmetry.”

The traditional method for detecting lameness is subjective, using expert visual evaluation of gait to identify the presence or absence and degree of asymmetries. Lame horses are described as having a disorder, defect or loss of function and this clinical diagnosis has associated welfare implications if the horse is still asked to perform.  

But advanced digital technology is starting to change all this. Optic motion capture or the use of inertial measurement units is now allowing researchers to study and quantify the horse’s gait; objective assessment against preset thresholds.

Professor Celia Marr, editor of the Equine Veterinary Journal said: “An important first step is for researchers and clinicians to start to discriminate clearly between ‘asymmetry’ and ‘lameness’ and not to use these as interchangeable terms when interpreting gait analysis data. Asymmetry is often, but not always, a hallmark of lameness, but is not a clinical term, whereas lameness is.”

The paper, Do we have to redefine lameness in the era of quantitative gait analysis, is published in the Autumn issue of the Equine Veterinary Journal. The paper is available free online at http://onlinelibrary.wiley.com/doi/10.1111/evj.12715/full .

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.